Hsui Jui-Yu, Chien Yin-Hsiu, Chu Shao-Yin, Lu Frank Leigh, Chen Huey-Ling, Ho Ming-Je, Lee Po-Huang, Hwu Wuh-Liang
Department of Pediatrics, National Taiwan University Hospital, 7 Chung-Shan South Road, Taipei 100, Taiwan.
Acta Paediatr Taiwan. 2003 May-Jun;44(3):171-3.
Methylmalonic acidemia (MMA) is an autosomal recessive disease of branched chain amino acid metabolism. The disease can be classified as vitamin B12-responsive or nonresponsive type. For the nonresponsive type, there is no curative treatment, and its prognosis is usually poor. We report one case that had vitamin B12-nonresponsive type MMA diagnosed at 3 days of age. The patient received liver transplantation at the age of 11 months. Continuous venovenous hemodialysis was performed immediately pre- and post-transplantation. The attack frequency of metabolic acidosis episodes decreased and the general condition of this patient improved after liver transplantation. So, although not curative, liver transplantation is an effective management for MMA.
甲基丙二酸血症(MMA)是一种常染色体隐性遗传性支链氨基酸代谢疾病。该疾病可分为维生素B12反应型或无反应型。对于无反应型,目前尚无治愈性治疗方法,其预后通常较差。我们报告1例3日龄时诊断为维生素B12无反应型MMA的病例。该患者11个月大时接受了肝移植。肝移植前后均立即进行了连续性静脉-静脉血液透析。肝移植后,该患者代谢性酸中毒发作的频率降低,一般状况有所改善。因此,尽管肝移植并非治愈性治疗,但却是MMA的一种有效治疗手段。